ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
89 hedge funds and large institutions have $426M invested in Endocyte, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 27 increasing their positions, 14 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
25% more funds holding
Funds holding: 71 → 89 (+18)
Holders
89
Holding in Top 10
3
Calls
$4.91M
Puts
$3.19M
Top Buyers
| 1 | +$51.8M | |
| 2 | +$39.1M | |
| 3 | +$28.3M | |
| 4 |
DM
Deerfield Management
New York
|
+$23.9M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$20M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$4.21M | |
| 3 | -$1.23M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.09M |
| 5 |
Renaissance Technologies
New York
|
-$901K |